FDA MedWatch - March 2009 FDA Patient Safety News is now available

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - March 2009 FDA Patient Safety News is now available
MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at http://www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch e-list. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to educators in healthcare facilities and academic institutions.

Stories in the March 2009 edition include:

Serious Skin Reactions in Asian Patients on Phenytoin and Fosphenytoin

Asian patients who test positive for the human leukocyte antigen allele HLA-B*1502 and take these anti-epileptic drugs may be at increased risk…

Higher Mortality for Certain Elderly Patients with Innohep (tinzaparin sodium injection)

Consider alternatives to Innohep for patients with kidney dysfunction who are 70 or older…

Limitations of Skin Patch Testing for Diagnosing Hypersensitivity Reactions with Abacavir

Patients with suspected hypersensitivity reactions should be diagnosed clinically because the accuracy of skin patch testing is unknown…  

Preventing Dosing Errors with Alteplase

The Institute for Safe Medication Practices (ISMP) points out that alteplase, which is tPA, is used for a number of indications at different dosages…

Potentially Fatal Salmonella Infections from Pet Turtles

Turtles may look like cute pets but they are responsible for an estimated 70,000 cases of Salmonella infections each year…

Caution Using Topical Anesthetics Prior to Mammography

Before using a topical anesthetic before a mammogram or other procedures, women should talk to their doctor about whether it is advisable…


You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDA HHS

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux